MA31170B1 - Dérivés de 2-amino-5,7-dihydro-6h-pyrrolo[3,4-d]pyrimidine servant d'inhibiteurs de la hsp-90 pour le traitement du cancer - Google Patents
Dérivés de 2-amino-5,7-dihydro-6h-pyrrolo[3,4-d]pyrimidine servant d'inhibiteurs de la hsp-90 pour le traitement du cancerInfo
- Publication number
- MA31170B1 MA31170B1 MA32149A MA32149A MA31170B1 MA 31170 B1 MA31170 B1 MA 31170B1 MA 32149 A MA32149 A MA 32149A MA 32149 A MA32149 A MA 32149A MA 31170 B1 MA31170 B1 MA 31170B1
- Authority
- MA
- Morocco
- Prior art keywords
- hsp
- inhibitors
- pyrrolo
- dihydro
- cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La présente invention concerne des composés de formule (i) et leurs sels acceptables sur le plan pharmaceutique, leur synthèse et leur utilisation en tant qu'inhibiteurs de la hsp 90.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88843307P | 2007-02-06 | 2007-02-06 | |
US2066108P | 2008-01-11 | 2008-01-11 | |
PCT/IB2008/000200 WO2008096218A1 (fr) | 2007-02-06 | 2008-01-25 | Dérivés de 2-amino-5,7-dihydro-6h-pyrrolo[3,4-d]pyrimidine en tant qu'inhibiteurs de la hsp 90 pour le traitement du cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
MA31170B1 true MA31170B1 (fr) | 2010-02-01 |
Family
ID=39367692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA32149A MA31170B1 (fr) | 2007-02-06 | 2009-08-06 | Dérivés de 2-amino-5,7-dihydro-6h-pyrrolo[3,4-d]pyrimidine servant d'inhibiteurs de la hsp-90 pour le traitement du cancer |
Country Status (22)
Country | Link |
---|---|
US (1) | US20100093696A1 (fr) |
EP (1) | EP2118111B1 (fr) |
JP (1) | JP4523073B2 (fr) |
KR (1) | KR20090116789A (fr) |
AP (1) | AP2009004954A0 (fr) |
AT (1) | ATE502944T1 (fr) |
AU (1) | AU2008212645A1 (fr) |
BR (1) | BRPI0807165A2 (fr) |
CA (1) | CA2677365A1 (fr) |
CO (1) | CO6220971A2 (fr) |
CR (1) | CR10963A (fr) |
CU (1) | CU20090141A7 (fr) |
DE (1) | DE602008005715D1 (fr) |
DO (1) | DOP2009000200A (fr) |
EA (1) | EA200970669A1 (fr) |
EC (1) | ECSP099565A (fr) |
IL (1) | IL200169A0 (fr) |
MA (1) | MA31170B1 (fr) |
MX (1) | MX2009008386A (fr) |
NI (1) | NI200900155A (fr) |
TN (1) | TN2009000329A1 (fr) |
WO (1) | WO2008096218A1 (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010018481A1 (fr) * | 2008-08-13 | 2010-02-18 | Pfizer Inc. | Composés 2-amino pyrimidine comme inhibiteurs puissants de l'hsp-90 |
GB0907284D0 (en) | 2009-04-28 | 2009-06-10 | Queen Mary & Westfield College | Compounds for inducing cellular apoptosis |
AR077405A1 (es) | 2009-07-10 | 2011-08-24 | Sanofi Aventis | Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer |
FR2949467B1 (fr) | 2009-09-03 | 2011-11-25 | Sanofi Aventis | Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation |
EP2519519A4 (fr) | 2009-12-30 | 2013-04-24 | Arqule Inc | Composés naphthalényl-pyrimidine substitués |
EP2752201A1 (fr) * | 2013-01-04 | 2014-07-09 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Inhibiteurs de HSP90 C-terminal pour traiter les adénomes hypophysaires |
US9447025B2 (en) | 2013-03-14 | 2016-09-20 | Kalyra Pharmaceuticals, Inc. | Bicyclic analgesic compounds |
CN105814013A (zh) | 2013-12-12 | 2016-07-27 | 卡利拉制药公司 | 双环烷基化合物及合成 |
JP6741343B2 (ja) | 2014-03-07 | 2020-08-19 | リキュリウム アイピー ホールディングス リミテッド ライアビリティー カンパニー | プロペラン誘導体および合成 |
ES2954453T3 (es) * | 2014-06-13 | 2023-11-22 | Yuma Therapeutics Inc | Compuestos de pirimidina y métodos que utilizan los mismos |
JP6833677B2 (ja) | 2014-09-17 | 2021-02-24 | リキュリウム アイピー ホールディングス リミテッド ライアビリティー カンパニー | 二環式化合物 |
US10227029B2 (en) * | 2015-08-07 | 2019-03-12 | Kawasaki Jukogyo Kabushiki Kaisha | Container holder attached to utility vehicle |
CA3063729A1 (fr) | 2017-05-15 | 2018-11-22 | Recurium Ip Holdings, Llc | Composes analgesiques |
WO2020243457A1 (fr) * | 2019-05-29 | 2020-12-03 | Viogen Biosciences, Llc | Composés et leurs utilisations thérapeutiques |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
SK287142B6 (sk) | 2000-02-15 | 2010-01-07 | Sugen, Inc. | Inhibítory proteínkináz na báze pyrolom substituovaného 2-indolinónu, farmaceutický prípravok s ich obsahom a ich použitie |
MXPA04007191A (es) * | 2002-01-23 | 2005-03-31 | Bayer Pharmaceuticals Corp | Derivados de pirimidina como inhibidores de rho-quinasa. |
US7312330B2 (en) * | 2003-12-24 | 2007-12-25 | Renovis, Inc. | Bicycloheteroarylamine compounds as ion channel ligands and uses thereof |
CA2602257A1 (fr) * | 2005-03-30 | 2006-10-05 | Conforma Therapeutics Corporation | Alkynyle pyrrolopyrimidines et analogues associes en tant qu'inhibiteurs de hsp90 |
-
2008
- 2008-01-25 US US12/524,892 patent/US20100093696A1/en not_active Abandoned
- 2008-01-25 WO PCT/IB2008/000200 patent/WO2008096218A1/fr active Application Filing
- 2008-01-25 EA EA200970669A patent/EA200970669A1/ru unknown
- 2008-01-25 JP JP2009548758A patent/JP4523073B2/ja not_active Expired - Fee Related
- 2008-01-25 BR BRPI0807165-9A patent/BRPI0807165A2/pt not_active IP Right Cessation
- 2008-01-25 AU AU2008212645A patent/AU2008212645A1/en not_active Abandoned
- 2008-01-25 KR KR1020097018581A patent/KR20090116789A/ko not_active Application Discontinuation
- 2008-01-25 AT AT08702335T patent/ATE502944T1/de not_active IP Right Cessation
- 2008-01-25 DE DE602008005715T patent/DE602008005715D1/de active Active
- 2008-01-25 MX MX2009008386A patent/MX2009008386A/es unknown
- 2008-01-25 CU CU20090141A patent/CU20090141A7/es unknown
- 2008-01-25 AP AP2009004954A patent/AP2009004954A0/xx unknown
- 2008-01-25 EP EP08702335A patent/EP2118111B1/fr active Active
- 2008-01-25 CA CA002677365A patent/CA2677365A1/fr not_active Abandoned
-
2009
- 2009-07-30 IL IL200169A patent/IL200169A0/en unknown
- 2009-08-04 TN TNP2009000329A patent/TN2009000329A1/fr unknown
- 2009-08-04 CR CR10963A patent/CR10963A/es unknown
- 2009-08-04 CO CO09081255A patent/CO6220971A2/es not_active Application Discontinuation
- 2009-08-05 NI NI200900155A patent/NI200900155A/es unknown
- 2009-08-06 EC EC2009009565A patent/ECSP099565A/es unknown
- 2009-08-06 MA MA32149A patent/MA31170B1/fr unknown
- 2009-08-06 DO DO2009000200A patent/DOP2009000200A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CU20090141A7 (es) | 2011-04-26 |
JP2010518066A (ja) | 2010-05-27 |
ATE502944T1 (de) | 2011-04-15 |
DE602008005715D1 (de) | 2011-05-05 |
JP4523073B2 (ja) | 2010-08-11 |
KR20090116789A (ko) | 2009-11-11 |
EA200970669A1 (ru) | 2010-02-26 |
DOP2009000200A (es) | 2009-09-15 |
US20100093696A1 (en) | 2010-04-15 |
MX2009008386A (es) | 2009-10-16 |
NI200900155A (es) | 2010-06-30 |
CA2677365A1 (fr) | 2008-08-14 |
CO6220971A2 (es) | 2010-11-19 |
EP2118111A1 (fr) | 2009-11-18 |
CR10963A (es) | 2009-08-27 |
EP2118111B1 (fr) | 2011-03-23 |
TN2009000329A1 (fr) | 2010-12-31 |
BRPI0807165A2 (pt) | 2014-05-06 |
AP2009004954A0 (en) | 2009-08-31 |
IL200169A0 (en) | 2010-04-15 |
ECSP099565A (es) | 2009-09-29 |
WO2008096218A1 (fr) | 2008-08-14 |
AU2008212645A1 (en) | 2008-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA31170B1 (fr) | Dérivés de 2-amino-5,7-dihydro-6h-pyrrolo[3,4-d]pyrimidine servant d'inhibiteurs de la hsp-90 pour le traitement du cancer | |
MA31574B1 (fr) | Dérivés de pyrazole et leur utilisation comme inhibiteurs de raf | |
MA31419B1 (fr) | Derives de pyridine | |
MA30709B1 (fr) | Derives de pyrido (2, 3-d) pyrimidinone et leur utilisation comme inhibiteurs de pi3. | |
MA30652B1 (fr) | Composes organiques | |
DK1678166T3 (da) | Proteinkinaseinhibitorer | |
MA29926B1 (fr) | Derives de pyrazine | |
MA32965B1 (fr) | Derives de sulfonamides | |
MA37142A3 (fr) | Dérivés de dihydro-benzo-oxazine et de dihydro-pyrido-oxazine | |
MA31655B1 (fr) | Pyrimidines cyclopenta [d] hydroxylés et méthoxylés utilisés en tant qu'inhibiteurs de la protéine kinase akt. | |
MA30952B1 (fr) | Cyclopenta [d] pyrimidines utiles en tant qu'inhibiteurs de la proteine kinase akt | |
TNSN07022A1 (fr) | Derives de pyridine | |
MA30053B1 (fr) | Derives [4-(benzo[b]thiophen-2-yl)-pyrimidin -2-yl]-amine en tant qu'inhibiteurs de ikk-beta pour le traitement du cancer et de maladies inflammatoires . | |
MA38138A1 (fr) | Dérivés inédits de quinolone | |
MA38080A1 (fr) | Dérivés substitués de phtalazin-1(2h)-one comme inhibiteurs sélectifs de la poly(adp-ribose) polymérase-1 | |
MA31679B1 (fr) | Cuclopentanes de pyrimidyle comme inhibiteurs de proteines kinases akt | |
MA34644B1 (fr) | Dérivés de pyrazole aminopyrimidine en tant que modulateurs du lrrk2 | |
MA32135B1 (fr) | Inhibiteurs de pim kinase et leurs procedes d'utilisation | |
MA34342B1 (fr) | Dérivés de la pipéridinone en tant qu'inhibiteurs de mdm2 pour le traitement du cancer | |
MA40225B1 (fr) | Composés dihydroisoquinolinone substitués | |
DE60206911D1 (de) | Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren | |
MA35749B1 (fr) | Dérivés nucléosidiques 4'-azido, 3'-fluoro substitués en tant qu'inhibiteurs de la réplication de l'arn du vhc | |
MA37891A1 (fr) | Alcoxypyrazoles comme activateurs de guanylate cyclase soluble | |
MA28562B1 (fr) | 1,3,4-oxadiazol-2-ones comme modulateurs de ppar delta et leur utilisation | |
MA34098B1 (fr) | Utilisation de nouveaux inhibiteurs pan-cdk pour le traitement de tumeurs |